Fulong Kangtai Biotechnology

Fulong Kangtai Biotechnology is a Chinese biopharmaceutical company primarily focused on the research, development, and production of human vaccines and diagnostic reagents. The company is best known for its work in the field of rabies prevention, having developed and commercialized human rabies vaccines. Beyond its core vaccine portfolio, Fulong Kangtai engages in the production of recombinant proteins and other biological products intended for both clinical and diagnostic use. Headquartered in Beijing, the company operates large-scale manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to supply the domestic Chinese market.